Roche Collaborates With PathAI To Expand Digital Pathology Capabilities For Companion Diagnostics
Roche Collaborates With PathAI To Expand Digital Pathology Capabilities For Companion Diagnostics
罗氏与PatHai合作扩展伴随诊断的数字病理学能力
- PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion diagnostics business.
- The image analysis algorithms will be deployed on Roche's navify Digital Pathology platform, allowing seamless integration into pathology laboratories worldwide.
- The collaboration between RTD and PathAI helps advance precision medicine by bringing together AI-interpretation and companion diagnostics, increasing patient access to targeted treatments.
- PathaI将独家与罗氏组织诊断（RTD）合作，为RTD的伴随诊断业务开发人工智能（AI）数字病理学算法。
- 图像分析算法将部署在罗氏的navify数字病理学平台上，从而可以无缝集成到全球病理学实验室中。
- RTD和PathaI之间的合作将人工智能解释和伴随诊断相结合，从而增加患者获得靶向治疗的机会，从而帮助推进精准医疗的发展。